Clinical Trial

Trial Protocol ID USOR 22167_IGM-8444-001

Trial Description

AN OPEN-LABEL, MULTICENTER, PHASE 1a/1b STUDY OF IGM-8444 AS A SINGLE AGENT AND IN COMBINATION IN SUBJECTS WITH RELAPSED, REFRACTORY, OR NEWLY DIAGNOSED CANCERS (IGM-8444-001)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Yousuf A. Gaffar, M.D.

Disease Types

ClinicalTrials.gov NCT ID

  • NCT04553692